At 16 eligible dogs per week, the SynergyMed model reaches nearly $2.5M in annual gross revenue opportunity. If those cases continue to leave the practice, the associated opportunity may leave too.
How the example is modeled
Modeled annual gross revenue opportunity
$2,496,000 calculated
Illustrative gross revenue before clinic costs, device costs, consumables, support, and other expenses.
Veterinarians, physicians, investors, and collaborators share what stands out, from clinical potential to partnership, investment, and real-world impact.
“Cancer is personal to me. I've lost close friends and relatives to cancer. I've sat with loved ones during treatment and seen first hand how limited and painful the options can be. That experience shaped my mission: to build better solutions for patients battling solid tumors”
The purchase case
SynergyVet is a high-consideration purchase. The value story needs to work clinically, operationally, and financially before a buyer moves forward.
Give owners an in-house treatment conversation while keeping evaluation, planning, and follow-up connected to the team they already trust.
Make advanced oncology capability visible to pet owners and referral partners without rebuilding the entire treatment environment.
Pair commercial terms with modeled case volume, procedure revenue, costs, and payback timing before internal approval.
Real veterinary evidence
Clinical trials conducted in dogs
Clinical grounding
SynergyMed has conducted clinical trials in dogs and collaborated with The Ohio State University. Qualified buyers can discuss available study context as part of the evaluation process.
Configuration & deployment
The quote process covers clinical goals, device configuration, sensor needs, setup requirements, demonstration timing, and commercial terms.
Clinic-ready footprint
Request pricing
Use one request for pricing, procurement, a demonstration, or a clinical-fit conversation. Our team will review the details and follow up with the right next step.
Tell us about your clinic, role, buying timeline, and clinical interest.
Review configuration, demonstration timing, setup, and procurement requirements.
Receive the appropriate pricing package and next-step conversation.
Buyer questions
Straight answers for clinics evaluating clinical fit, economics, and procurement readiness.
Veterinary hospitals, practice owners, medical directors, institutions, and clinical buyers evaluating an in-house oncology service can use this page to begin a qualified procurement conversation.
Yes. SynergyMed is ready to discuss veterinary device sales, demonstrations, configuration, quote requests, and procurement next steps with qualified clinics and institutions.
SynergyMed has collaborated with The Ohio State University and conducted clinical trials in dogs. Available study context can be discussed during a qualified quote or demonstration conversation.
The illustrative example uses 16 dogs per week, $3,000 in modeled revenue per procedure, and 52 weeks, producing $2,496,000 in modeled annual gross revenue opportunity. Clinic costs and results vary, so buyers should adjust the ROI calculator for their own practice.
Current areas of interest include mast cell tumors, mammary tumors, carcinoma, and soft tissue sarcoma workflows. Clinical fit should be reviewed with the SynergyMed team.
